1959
DOI: 10.1001/archpedi.1959.02070010792005
|View full text |Cite
|
Sign up to set email alerts
|

Trimethadione (Tridione) Nephrosis

Abstract: Trimethadione (Tridione) was first shown to be highly specific in petit mal epilepsy by Perlstein in 1946, and this has been amply confirmed by Lennox and others.1 It was recognized early that toxic side-effects may follow prolonged administration of the drug, such as dermatitis, hepatitis, photophobia, drowsiness, nausea, aplastic anemia, and agranulocytosis. Barnett and co-workers2 reported the first case of nephrotic syndrome following the use of trimethadione in 1948. Since then, four more cases have been … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1961
1961
1963
1963

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…A nephrotic syndrome and other nephrotoxic effects of trimethadione have been reported. s4 , 104 More recently, alopecia has been reported as a reversible side effect of trimethadione therapy. 55 The substitution of a less toxic but related single agent such as paramethadioneo generally offers the patient much less effective therapy.…”
Section: Ftridionementioning
confidence: 99%
“…A nephrotic syndrome and other nephrotoxic effects of trimethadione have been reported. s4 , 104 More recently, alopecia has been reported as a reversible side effect of trimethadione therapy. 55 The substitution of a less toxic but related single agent such as paramethadioneo generally offers the patient much less effective therapy.…”
Section: Ftridionementioning
confidence: 99%